Read More

Omega Flex, Inc. Board and Organizational Changes; Kevin R. Hoben Will Be Executive Chairman Of The Co; Dean W. Rivest Will Replace Mr. Hoben As Chief Executive Officer; Edwin B. Moran Will Replace Mr. Rivest As President, Effective January 1, 2024

We are pleased to announce that on December 7, 2023, on the recommendation of our Nominating/Governance Committee, effective January 1, 2024, our Board of Directors unanimously elected Edwin B. Moran as a Class 2

OFLX

Read More

Reneo Pharmaceuticals Inc Says On Dec 26, Concentra, An Affiliate Of Tang Capital Partners, Sent Acquisition Proposal To The Co; On Behalf Of Concentra Biosciences, Submit Non-Binding Proposal To Acquire 100% Of Equity Of Reneo For $1.80 Per Share

Concentra Biosciences, LLC4747 Executive Drive, Suite 210 | San Diego, CA 92121December 26, 2023Board of DirectorsReneo Pharmaceuticals, Inc.c/o Gregory J. Flesher, President and Chief Executive Officer18575

RPHM

Read More

Intuitive Machines Inc’s Erik Sallee Is Departing As Chief Financial Officer, Effective January 26, 2024; Steven Vontur Will Serve As Our Interim CFO During This Transition; Peter McGrath To Assume Role Of Chief Operating Officer

Effective January 2, 2024, Peter McGrath will assume the position of Senior Vice President and Chief Operating Officer. In his new role, Mr. McGrath will focus on the daily operations of the business and focus on

LUNR